Sirolimus and FTY720: new approaches to transplant immunosuppression

By Kahan B.D.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2520-2522

Elsevier

Access to resources Recommend Favorite

Approaches to immunosuppression in Behçet's disease

By Comarmond Cloé   Wechsler Bertrand   Cacoub Patrice   Saadoun David  

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 743-754

Future Medicine

Access to resources Recommend Favorite

Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols

By Gentil M.A.   Lopez M.   Gonzalez-Roncero F.   Rodriguez-Algarra G.   Pereira P.   Lopez R.   Martinez M.   Toro J.   Mateos J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1748-1750

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

By Braun F.   Schutz E.   Peters B.   Talaulicar R.   Grupp C.   Undre N.   Schafer A.   Armstrong V.W.   Oellerich M.   Ringe B.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Immunosuppression protocols for HLA identical renal transplant recipients

By Keitel E.   Santos A.F.   Alves M.A.   Neto J.P.   Schaefer P.G.   Bittar A.E.   Goldani J.C.   Pozza R.   Bruno R.M.   See D.   Garcia C.D.   Garcia V.D.  

Transplantation Proceedings, Vol. 35, Iss. 3, 2003-05 ,pp. : 1074-1075

Elsevier

Access to resources Recommend Favorite